Sunday July 05 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Datamonitor's October edition of the IDI Review brings you the latest news, analysis and research covering immune disorders and inflammation.

It covers all the major current business issues and events, including R&D, licensing deals, alliances and joint ventures, and regulatory decisions.

Scope

  • Strategic insight into the future shape of IDI companies and markets

  • The most significant IDI industry news compiled into one monthly update

  • Expert analysis into the implications of the month's important IDI industry events

  • Insight into the future shape of the market for players at all levels

  • All the month's IDI stories in headline and summary form

Report Highlights

Out of the dozens of topics covered in this month's review, the most important include:

* Roche released the results of the four-year landmark Xendos study involving 3,304 patients which demonstrated that the weight loss medication Xenical can significantly prevent or delay the development of type 2 diabetes.

* Bayer has filed for approval for its immune globulin intravenous drug, Gamunex. It's a purer alternative to Bayer's existing Gamimune; its major indication is primary immunodeficiency.

Reasons to Purchase

  • Not only keeps you updated about industry events - it also gives you opinion and insight

  • Draws upon Datamonitor analysts' extensive experience to bring you our perspective on the impact of the latest events

  • Provides you with your own news archive to track company and industry progress, giving you an extensive reference to relevant events and issues

R&D UPDATE: EPHARMA

The most significant news in ePharma R&D, compiled into one monthly update.

R&D UPDATE: EPYHSICIAN

The most significant news in ePhysician R&D, compiled into one monthly update.

FEATURE ANALYSIS

Analyst-written feature articles, featuring the latest insights into the industry

  • ePharma: targeting the online health conscious

NEWS HEADLINES - EPHARMA

All the month's ePharma news stories in headline and summary form

NEWS HEADLINES - EPYHSICIAN

All the month's ePhysician news stories in headline and summary form

To order - click here! 

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.